other

Updated:

Vispero

Vispero, headquartered in Clearwater, Florida, is the parent company of Freedom Scientific, a brand founded from the merger of two assistive technology...

Vispero

Vispero, headquartered in Clearwater, Florida, is the parent company of Freedom Scientific, a brand founded from the merger of two assistive technology pioneers. The company's wealth origin is not publicly disclosed, and it does not operate as a single or multi-family office. Vispero's business is the development and sale of accessibility hardware and software for blind and low-vision users. The company's product line includes three core categories: low vision solutions (video magnifiers), blindness solutions (braille displays such as the Focus series), and software (JAWS screen reader, ZoomText magnifier, and Fusion). Distribution targets include K-12 schools and libraries in the US through ARPA funding, and global markets via events like SightCity Frankfurt. The company names no direct investment portfolio, co-investments, or fund commitments. Vispero does not disclose team size, AUM, or additional offices. A May 2026 software release cycle delivered JAWS 2026.2605.43 and ZoomText 2026.2605.28. The company maintains a charitable program spotlighting K-12 students who use its technology, but no separate philanthropic foundation is named. No recent fundraising or ownership change has been reported. Unlike a traditional family office or asset manager, Vispero is a commercial operating company selling assistive technology products. Its structural differentiator is the fusion of hardware, software, and educational outreach under one brand, with revenue tied to government funding cycles and institutional procurement rather than capital markets.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Clearwater

Corporate office

Clearwater, FL, United States

Sector focus

Assistive TechnologySoftwareHardware

Frequently asked questions

What does Vispero do?

Vispero is the parent company of Freedom Scientific, which develops assistive technology for people who are blind or have low vision. Products include the JAWS screen reader, ZoomText magnifier, Focus braille displays, and desktop and portable video magnifiers. The company sells primarily to schools, libraries, and enterprises, often via government funding programs like the American Recovery Plan Act.

Is Vispero a family office?

No. Vispero is an operating company that sells assistive technology hardware and software. It does not manage capital for outside investors or operate as an investment vehicle. Public records and the company's website show no AUM, investment portfolio, or fund structure.

Who owns Vispero?

Ownership of Vispero is not publicly disclosed. The company does not list principals, board members, or shareholders on its website. No press reports identify a single family or individual as the controlling owner.

How does Vispero distribute its products?

Vispero sells through its brand Freedom Scientific via direct sales and events such as SightCity Frankfurt and Envision & VisionServe Alliance conferences. In the US, the company highlights ARPA funds as a means for schools and libraries to purchase its assistive technology. Software is distributed as annual subscription and SMA renewal models.

Does Vispero have any philanthropic programs?

Yes. Freedom Scientific runs a program featuring K-12 students in the US who are blind or visually impaired and use its technology to achieve academic goals. No separate foundation or charitable trust is named on the company website.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo